The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Ended red today due to 464k sell late doors. I’ll be hanging on to mine thanks. Only a matter of time before this business is absorbed into a big pharma
There seem to be more trading updates this year, if only to say how the business is doing under pandemic conditions. Hence I expect there will be an update in The second half of July.
Looking for indications that the last update has been followed through or perhaps even improved.
Reiterate positive developments for Proleukin and the other recently announced deals progressing satisfactorily.
Next final results are due September . Not too long to wait if there is no updates in the meantime.
Next week- probably Wed/Thur based on last year... should change sentiment either posumitively or negatively! I'm hoping for organic growth of 9%+, debt at £360m max, and some positive noises on Proluken. Fingers crossed!
Unless there is a blockbuster trading update coming.
The changes in major holdings announced today are mostly a change in ultimate ownership of the investment manager with a small reduction. Nothing of note.
" I have noted the ceo of AstraZeneca talking up the sp saying that a vaccine is imminent. He’s said it twice over the last month or so. Probably his dog has bought shares the day before."
or angling for a pay rise, given he claims to be the lowest paid CEO in eu/us pharma circles
oh, and just for the record, i didn't invest, i got lumbered with these overpriced shares
I was happy to take what was offered, although still believe that it was a low ball offer, and Rigg and his cronies took care of themselves first and foremost, Quantum was on the rise, and had potential, hence why Clinigen snapped it up when it had the chance.
What i am not happy with, is that once overvaluing this POS during the run up to giving us shares here, meant the offer was even lower than the cheap price they got it for.
I have no opinion one way or another on this piece of crap, when i get what is owed i'm out, and will never touch anything this lot are involved in again, do i think it will rise eventually, yes, because if they've done it once, they'll do it again, and i'll step off on the next pump before they print some more confetti to buy another company.
CrystalBallBroke, I don’t know when you invested in Quantum Pharma, but you need to give up the bitterness towards Clinigen and look forwards. Q traded at 160p in 2015, in 2016 it traded under 40p and was about 50p when Clinigen made its approach and ultimately offered 82p, 37p in cash and equivalent of 45p in cash.....even if this was 20% overvalued the offer was atleast 73p per share and the shareholding gave you and others a stake in a larger business that was expected to grow. That the SP did not continue upwards is unfortunate, but it is still a double your money takeover from the lows of 2016 or a loss of 50% if you bought in at 160p. Either way it is historic and not relevant today.
If you believe the current BOD are charlatans then you should be selling or shorting this share.
Clearly you are still invested to get your perceived losses back so you think the prospects of this are good. Why not express what you think of the current groups strategy and business prospects? That will help us all who hold now and don’t care about the past.
Well said crystalballbroke, there’s one thing I’ve learnt which isn’t much, is that never ever trust brokers or directors. Alls they want is your money. They are not your friends . I have noted the ceo of AstraZeneca talking up the sp saying that a vaccine is imminent. He’s said it twice over the last month or so. Probably his dog has bought shares the day before.
There may well be a vaccine made that works but to keep saying it without knowing it’s going to work by the ceo is not on. Now having said that I will buy AstraZeneca on any good drop.
£353k buy just gone through.
we saw practically nothing from that deal, any profit vanished because the weak willed BOD took their pound of flesh in the deal and positions here to leave shortly after with golden handshakes, and the low ball offer at the time they accepted/recommended, was over 50% paid in useless shares here valued at least £2 over their true value, which by the time we got them were over £2 lower each than what we should have gotten if this scheming group had paid for what it bought, instead of just printing some more shares.
I've been stuck in this POS since then, because i want what was promised and owed to me
Those would be the quantum shareholders that had seen their share price sink to 50p and accepted 80p partly in cash part shares. Overpaying for an acquisition is always a risk and often happens.
Quantum shareholders still in profit if you think of 50p as the value of each share.
i'd take 11.25 - this POS has never been worth that, last time thy pumped it that high was to F over quantum pharma share holders
Here’s my take on a possible scenario:
New broker tests the water to see if there is a potential buyer.
Buyer does not get access to the books and looks at recent SP highs and suggests this as a deal price.
BOD reckon this is much too low and continue to not allow access.
Bidder leaks the potential offer to try to force engagement
BOD considers trading update to be strong and wants a higher offer to open the books.
Bidder decides to wait for FY numbers, they can return with a number whenever they want, but the BOD needs strong numbers to justify a higher price.
Expecting a good trading update mid July.
Queried my broker a to why they sent me a corporate action notice that made out CLIN had said they were being bought out..... Using a link to Proactive to justify the news.
They admitted they'd sent the communique "too early". An explanation I'd say was not quite matching the reality of them painting rumours with a veneer of credibility.
If every broker rebadged every share website's stories and rumours then the messaging from them would be as bad as some bulletin boards. Takes my faith in them down a notch....
I would rather it go on to bigger things than be sold
Yeah, adjusted EPS is looking likely to come in around 75p for the full year, so at 15x PE (which is a tad lower than they've historically been), that gives £11.25... but that's not exactly a knockout bid - I'd expect them to pay around 18x, which is £13.50... but it's old news, so may not happen. Let's just see what FY19 results bring
But the lack of SP movement indicates a lack of belief in any bidder emerging.
£14 is into knock out bid territory. Hard for the Board to refuse to consider a bid at such a level.
10-11 is too cheap
Advent must be trying to get them on the cheap. They can have mine for 14 quid.
Clinigen are looking at £14/£15 per share to sell
Looks interesting maybe an RNS. Just a guess.
Added a few 100 shares this morning in anticipation of a decent trading update and speculative cover on a bid, although I consider this a bonus if it happens.